Dried blood spots and sparse sampling: A practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants

British Journal of Clinical Pharmacology

Volumn 75, Issue 3, 2013, Pages 805-813

  Patel, Parul ^a,c   Mulla, Hussain ^b   Kairamkonda, Venkatesh ^c   Spooner, Neil ^d   Gade, Sonya ^d   Della Pasqua, Oscar ^d   Field, David J ^c,e   Pandya, Hitesh C ^b,e  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Blood; Methodology; Neonates; Paediatrics; Population pharmacokinetics; Therapeutics

Indexed keywords

CAFFEINE;

APNEA; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; DRUG ABSORPTION; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HUMAN; INFANT; LIQUID CHROMATOGRAPHY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; NEWBORN APNEA; NEWBORN INTENSIVE CARE; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VULNERABLE POPULATION;

APNEA; BIRTH WEIGHT; CAFFEINE; CENTRAL NERVOUS SYSTEM AGENTS; DRIED BLOOD SPOT TESTING; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MODELS, THEORETICAL; PROSPECTIVE STUDIES; SPECIMEN HANDLING;

EID: 84873438524     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04392.x     Document Type: Article

References (27)

1. Patel P. (2011) An investigation into the use of dried blood spot analysis in pharmacokinetic studies. PhD Thesis, De Montfort University, Leicester. Available at www.dora.dmu.ac.uk/bitstream/handle/2086/5999/e-thesis.pdf?sequence=1 (accessed 30 January 2013).
2. Ziemniak C, George-Agwu A, Moss WJ, Ray SC, Persaud DA. Sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J Virol Methods 2006; 136: 238-247.
3. Mwaba P, Cassol S, Nunn A, Pilon R, Chintu C, Janes M, Zumla A. Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infectedafrican patients. Lancet 2003; 362: 2067-2068.
4. Mei JV, Alexander JR, Adam BW, Hannon WH. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 2001; 131: 1631S-1636.
5. Keevil BG. The analysis of dried blood spot samples using liquid chromatography tandem mass spectrometry. Clin Biochem 2011; 44: 110-118.
6. Spooner N, Ramakrishnan Y, Barfield M, Dewit O, Miller S. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations. Bioanalysis 2010; 2: 1515-1522.
7. Beaudette P, Bateman KP. Discovery stage pharmacokinetics using dried blood spots. J Chromatogr B 2004; 809: 153-158.
8. Mohammed BS, Cameron GA, Cameron L, Hawksworth GH, Helms PJ, McLay JS. Can finger-prick sampling replace venous sampling to determine the pharmacokinetic profile of oral paracetamol? Br J Clin Pharmacol 2010; 70: 52-56.
9. González AG, Zavala LC, Moreno AP, San Juan ER, Ferrara JG, Espinosa LR, Marcelín Jiménez G. Pharmacokinetics of diphenylboroxazolidones of L-α-amino acids with activity on the CNS: quantification in rat DBS by UPLC-MS/MS. Bioanalysis 2011; 3: 439-448.
10. Spooner N, Lad R, Barfield M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal Chem 2009; 81: 1557-1563.
11. Lad R. Validation of individual quantitative methods for determination of cytochrome P450 probe substrates in human dried blood spots with HPLCMS/MS. Bioanalysis 2010; 2: 1849-1861.
12. Filippi L, la Marca G, Fiorini P, Poggi C, Cavallaro G, Malvagia S, Pellegrini-Giampietro DE, Guerrini R. Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy. Epilepsia 2009; 50: 2355-2361.
13. Patel P, Tanna S, Mulla H, Kairamkonda V, Pandya H, Lawson G. Dexamethasone quantification in dried blood spot samples using LC-MS: the potential for application to neonatal pharmacokinetic studies. J Chromatogr B 2010; 878: 3277-3282.
14. Suyagh MF, Iheagwaram G, Kole PL, Millership J, Collier P, Halliday H, McElnay JC. Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling. Pediatrics 2011; 127: e367-374.
15. Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A, Neims AH. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 1979; 94: 663-668.
16. Gorodischer R, Karplus M. Pharmacokinetic aspects of caffeine in premature infants with apnoea. Eur J Clin Pharmacol 1982; 22: 47-52.
17. Thomson AH, Kerr S, Wright S. Population pharmacokinetics of caffeine in neonates and young Infants. Ther Drug Monit 1996; 18: 245-253.
18. Lee T, Charles B, Steer P, Flenady V, Shearman A. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity. Clin Pharmacol Ther 1997; 61: 628-640.
19. Charles BG, Townsend SR, Steer PA, Flenady VJ, Gray PH, Shearman A. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit 2008; 30: 709-716.
20. Giacoia G, Jungbluth G, Jusko W. Effect of formula feeding on oral absorption of caffeine in premature infants. Dev Pharmacol Ther 1989; 12: 205-210.
21. Falcão AC, Fernández de Gatta MM, Delgado Iribarnegaray MF, Santos Buelga D, García MJ, Dominguez-Gil A, Lanao JM. Population pharmacokinetics of caffeine in premature neonates. Eur J Clin Pharmacol 1997; 52: 211-217.
22. Karlsson MO, Sheiner LB. The importance of modeling interoccasion variability in population pharmacokinetic analyses. J Pharmacokinet Pharmacodyn 1993; 21: 735-750.
23. Mordenti J, Chen SA, Moore JA, Ferraiolo BL, Green JD. Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharm Res 1991; 8: 1351-1359.
24. Mahmood I. Theoretical versus empirical allometry: facts behind theories and application to pharmacokinetics. J Pharm Sci 2010; 99: 2927-2933.
25. Rowland M, Emmons G. Use of dried blood spots in drug development: pharmacokinetic considerations. Am Assoc Pharm Sci J 2010; 12: 290-293.
26. Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis 2010; 2: 1385-1395.
27. Ritu A, William C, Hudson BY, Paul B. Dried blood spot analysis - consistent spot homogeneity with variable spot punch locations. 59th American society for mass spectrometry conference on mass spectrometry and allied topics Denver 2011; Abstract THP 116.